Clonal tracing of Sox9+ liver progenitors in mouse oval cell injury

Authors

  • Branden D. Tarlow,

    Corresponding author
    1. Department of Cell and Developmental Biology, Oregon Health & Science University, Portland, OR
    • Address reprint requests to: Branden Tarlow, Oregon Health & Science University, 3181 SW Sam Jackson Park Road, Mail Code L321, Portland, OR 97034. E-mail: btarlow@gmail.com; fax: 503-418-5044.

    Search for more papers by this author
  • Milton J. Finegold,

    1. Department of Pathology, Baylor College of Medicine, Houston, TX
    Search for more papers by this author
  • Markus Grompe

    1. Oregon Stem Cell Center, Papé Family Pediatric Research Institute, Oregon Health & Science University, Portland, OR
    Search for more papers by this author

  • This study was supported by the National Institute of Diabetes and Digestive and Kidney Diseases of the National Institutes of Health (F30-DK095514 [to B.T.], R01 DK051592 [to M.G.], and P30 DK56338 [to M.F.]) and the Knight Cancer Institute.

  • Potential conflict of interest: Dr. Grompe consults for, owns stock in, and has intellectual property rights in Yecuris. He has intellectual property rights in Novus.

Abstract

Proliferating ducts, termed “oval cells,” have long been thought to be bipotential, that is, produce both biliary ducts and hepatocytes during chronic liver injury. The precursor to oval cells is considered to be a facultative liver stem cell (LSC). Recent lineage tracing experiments indicated that the LSC is SRY-related HMG box transcription factor 9 postive (Sox9+) and can replace the bulk of hepatocyte mass in several settings. However, no clonal relationship between Sox9+ cells and the two epithelial liver lineages was established. We labeled Sox9+ mouse liver cells at low density with a multicolor fluorescent confetti reporter. Organoid formation validated the progenitor activity of the labeled population. Sox9+ cells were traced in multiple oval cell injury models using both histology and fluorescence-activated cell sorting. Surprisingly, only rare clones containing both hepatocytes and oval cells were found in any experiment. Quantitative analysis showed that Sox9+ cells contributed only minimally (<1%) to the hepatocyte pool, even in classic oval cell injury models. In contrast, clonally marked mature hepatocytes demonstrated the ability to self-renew in all classic mouse oval cell activation injuries. A hepatocyte chimera model to trace hepatocytes and nonparenchymal cells also demonstrated the prevalence of hepatocyte-driven regeneration in mouse oval cell injury models. Conclusion: Sox9+ ductal progenitor cells give rise to clonal oval cell proliferation and bipotential organoids, but rarely produce hepatocytes in vivo. Hepatocytes themselves are the predominant source of new parenchyma cells in prototypical mouse models of oval cell activation. (Hepatology 2014;60:278–289)

Ancillary